Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin

Journal of Experimental Medicine

Volumn 201, Issue 4, 2005, Pages 509-515

  Vermi, William ^a   Riboldi, Elena ^a   Wittamer, Valerie ^b   Gentili, Francesca ^a   Luini, Walter ^c   Marrelli, Simona ^a   Vecchi, Annunciata ^c   Franssen, Jean Denis ^d   Communi, David ^b   Massardi, Luisa ^a   Sironi, Marina ^c   Mantovani, Alberto ^c,e   Parmentier, Marc ^b   Facchetti, Fabio ^a   Sozzani, Silvano ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d Euroscreen SA   (Belgium)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD123 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; PROTEIN; PROTEIN CHEMERIN; PROTEIN CHEMR23; RECEPTOR; RECOMBINANT PROTEIN; SERPENTINE; SERPENTINE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LANGERHANS CELL; LYMPH NODE; LYMPHOID ORGAN; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN INFLAMMATION; SKIN LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TONSIL; VENULE;

CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; CHEMOTACTIC FACTORS; DENDRITIC CELLS; ENDOTHELIAL CELLS; HUMANS; LIGANDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOID TISSUE; MYELOID CELLS; PLASMA CELLS; RECEPTORS, CHEMOKINE; SKIN; VENULES;

EID: 20044369873     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041310     Document Type: Article

References (30)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
2. Steinman, R.M., D. Hawiger, and M.C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
3. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S, Miltenyi, D.W. Buck, and J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-6046.
4. Shortman, K., and Y.J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
5. Facchetti, F., W. Vermi, D. Mason, and M. Colonna. 2003. The plasmacytoid monocyte/interferon producing cells. Virchows Arch. 443:703-717.
6. Banchereau, J., B. Pulendran, R. Steinman, and K. Palucka. 2000. Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries? J. Exp. Med. 192:F39-F44.
7. Colonna, M., A. Krug, and M. Cella. 2002. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14:373-379.
8. Banchereau, J., V. Pascual, and A.K. Palucka. 2004. Autoimmuniry through cytokine-induced dendritic cell activation. Immunity. 20:539-550.
9. Penna, G., S. Sozzani, and L. Adorini. 2001. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167:1862-1866.
10. Wittamer, V., J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S. Brezillon, R. Tyldesley, C. Blanpain, M. Detheux, et al. 2003. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198:977-985.
11. Wittamer, V., F. Gregoire, P. Robberecht, G. Vassart, D. Communi, and M. Parmentier. 2004. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279:9956-9962.
12. Krug, A., R. Uppaluri, F. Facchetti, B.C. Dorner, K.C. Sheehan, R.D. Schreiber, M. Cella, and M. Colonna. 2002. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 169:6079-6083.
13. Vanbervliet, B., N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, F. Briere, G. Trinchieri, and C. Caux. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198:823-830.
14. Nagpal, S., S. Patel, H. Jacobe, D. DiSepio, C. Ghosn, M. Malhotra, M. Teng, M. Duvic, and R.A. Chandraratna. 1997. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109:91-95.
15. Adams, A.E., Y. Abu-Amer, J. Chappel, S. Stueckle, F.P. Ross, S.L. Teitelbaum, and L.J. Suva. 1999. 1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast-supporting stromal cells. J. Cell. Biochem. 74:587-595.
16. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549-555.
17. Engering, A., S.J. Van Vliet, K. Hebeda, D.G. Jackson, R. Prevo, S.K. Singh, T.B. Geijtenbeek, H. Van Krieken, and Y. Van Kooyk. 2004. Dynamic populations of dendritic cell-specific ICAM-3 grabbing non-integrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am. J. Pathol. 164:1587-1595.
18. Soilleux, E.J., L.S. Morris, G. Leslie, J. Chehimi, Q. Luo, E. Levroney, J. Trowsdale, L.J. Montaner, R.W. Doms, D. Weissman, et al. 2002. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71:445-457.
19. Geijtenbeek, T.B., D.J. Krooshoop, D.A. Bleijs, S.J. van Vliet, G.C. van Duijnhoven, V. Grabovsky, R. Alon, C.G. Figdor, and Y. van Kooyk. 2000. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 1:353-357.
20. Geissmann, F., M.C. Dieu-Nosjean, C. Dezutter, J. Valladeau, S. Kayal, M. Leborgne, N. Brousse, S. Saeland, and J. Davoust. 2002. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196:417-430.
21. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919-923.
22. von Andrian, U.H., and T.R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867-878.
23. Miyasaka, M., and T. Tanaka. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4:360-370.
24. Wollenberg, A., M. Wagner, S. Gunther, A. Towarowski, E. Tuma, M. Moderer, S. Rothenfusser, S. Wetzel, S. Endres, and G. Hartmann. 2002. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Invest. Dermatol. 119:1096-1102.
25. Breiteneder-Geleff, S., A. Soleiman, H. Kowalski, R. Horvat, G. Amann, E. Kriehuber, K. Diem, W. Weninger, E. Tschachler, K. Alitalo, and D. Kerjaschki. 1999. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154:385-394.
26. Vermi, W., R. Bonecchi, F. Facchetti, D. Bianchi, S. Sozzani, S. Festa, A. Berenzi, M. Cella, and M. Colonna. 2003. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J. Pathology. 200:255-268.
27. de Fouw, N.J., V.W. van Hinsbergh, Y.F. de Jong, F. Haverkate, and R.M. Bertina. 1987. The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells. Thromb. Haemost. 57:176-182.
28. van Hinsbergh, V.W., D. Binnema, M.A. Scheffer, E.D. Sprengers, T. Kooistra, and D.C. Rijken. 1987. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis. 7:389-400.
29. Ades, E.W., F.J. Candal, R.A. Swerlick, V.G. George, S. Summers, D.C. Bosse, and T.J. Lawley. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99:683-690.
30. Candal, F.J., S. Rafii, J.T. Parker, E.W. Ades, B. Ferris, R.L. Nachman, and K.L. Kellar. 1996. BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics. Microvasc. Res. 52:221-234.